Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancerDanish Memon, Matthew D. Hellmann, Darwin Ye et al.|Cancer Cell|2024Cited by 177
Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapyGeorge Fromm, Taylor H. Schreiber|Journal for ImmunoTherapy of Cancer|2018Cited by 49
LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint BlockadeKyung Jin Yoo, George Fromm|The Journal of Immunology|2022Cited by 19